| Semisynthetic quercetin derivatives with potent antitumor activity in colon carcinoma A Mukherjee, S Mishra, NK Kotla, K Manna, S Roy, B Kundu, ... Acs Omega 4 (4), 7285-7298, 2019 | 41 | 2019 |
| Structural evolution and translational potential for agonists and antagonists of endosomal toll-like receptors A Talukdar, D Ganguly, S Roy, N Das, D Sarkar Journal of Medicinal Chemistry 64 (12), 8010-8041, 2021 | 30 | 2021 |
| Activity-guided development of potent and selective toll-like receptor 9 antagonists B Paul, O Rahaman, S Roy, S Pal, S Satish, A Mukherjee, AR Ghosh, ... European Journal of Medicinal Chemistry 159, 187-205, 2018 | 17 | 2018 |
| Design and development of benzoxazole derivatives with toll-like receptor 9 antagonism S Roy, A Mukherjee, B Paul, O Rahaman, S Roy, G Maithri, B Ramya, ... European Journal of Medicinal Chemistry 134, 334-347, 2017 | 14 | 2017 |
| Development, optimization, and in vivo validation of new imidazopyridine chemotypes as dual TLR7/TLR9 antagonists through activity-directed sequential incorporation of relevant … N Das, P Bandopadhyay, S Roy, BP Sinha, UG Dastidar, O Rahaman, ... Journal of Medicinal Chemistry 65 (17), 11607-11632, 2022 | 9 | 2022 |
| Synthesis and characterization of new potent TLR7 antagonists based on analysis of the binding mode using biomolecular simulations S Pal, B Paul, P Bandopadhyay, N Preethy, D Sarkar, O Rahaman, ... European Journal of Medicinal Chemistry 210, 112978, 2021 | 9 | 2021 |
| Glycan Modulation of Insulin‐like Growth Factor‐1 Receptor RS Boothello, NV Sankaranarayanan, JC Sistla, B Nagarajan, C Sharon, ... Angewandte Chemie 134 (49), e202211320, 2022 | 8 | 2022 |
| Copper-catalyzed selective C–N bond formation with 2-amino, 2-hydroxy and 2-bromo-5-halopyridine S Roy, B Paul, A Mukherjee, B Kundu, A Talukdar RSC advances 7 (70), 44366-44370, 2017 | 5 | 2017 |
| Blocking toll-like receptor 9 signaling with small molecule antagonist A Talukdar, D Ganguly, B Paul, A Mukherjee, ROY Shounak, S Roy, ... US Patent App. 16/086,926, 2019 | 4 | 2019 |
| PURINE BASED COMPOUNDS AS TOLL-LIKE RECEPTOR 9 ANTAGONIST A TALUKDAR, D GANGULY, A MUKHERJEE, B PAUL, O RAHAMAN, ... WO Patent WO/2019/092,739, 2019 | 3 | 2019 |
| Hit-to-lead optimization of 2-aminoquinazolines as anti-microbial agents against Leishmania donovani N Das, J Roy, B Patra, E Saunders, D Sarkar, S Goon, BP Sinha, S Roy, ... European Journal of Medicinal Chemistry 269, 116256, 2024 | | 2024 |
| Design and Synthesis of Potent Small Molecule Antagonists of TLR9 S Roy Kolkata, 0 | | |
Arindam TalukdarIndian Institute of Chemical Biology- CSIR在 iicb.res.in 的电子邮件经过验证
